These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7849711)

  • 21. LOH and mutation analysis of CDKN2 in primary human ovarian cancers.
    Campbell IG; Foulkes WD; Beynon G; Davis M; Englefield P
    Int J Cancer; 1995 Oct; 63(2):222-5. PubMed ID: 7591208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
    Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
    Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rates of p16 (MTS1) mutations in primary tumors with 9p loss.
    Cairns P; Mao L; Merlo A; Lee DJ; Schwab D; Eby Y; Tokino K; van der Riet P; Blaugrund JE; Sidransky D
    Science; 1994 Jul; 265(5170):415-7. PubMed ID: 8023167
    [No Abstract]   [Full Text] [Related]  

  • 24. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus.
    Kamb A; Shattuck-Eidens D; Eeles R; Liu Q; Gruis NA; Ding W; Hussey C; Tran T; Miki Y; Weaver-Feldhaus J
    Nat Genet; 1994 Sep; 8(1):23-6. PubMed ID: 7987388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
    Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma.
    Caldas C; Hahn SA; da Costa LT; Redston MS; Schutte M; Seymour AB; Weinstein CL; Hruban RH; Yeo CJ; Kern SE
    Nat Genet; 1994 Sep; 8(1):27-32. PubMed ID: 7726912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased p16 levels correlate with pRb alterations in human urothelial cells.
    Yeager T; Stadler W; Belair C; Puthenveettil J; Olopade O; Reznikoff C
    Cancer Res; 1995 Feb; 55(3):493-7. PubMed ID: 7834615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High frequency of chromosome 9 deletion in ovarian cancer: evidence for three tumour-suppressor loci.
    Devlin J; Elder PA; Gabra H; Steel CM; Knowles MA
    Br J Cancer; 1996 Feb; 73(4):420-3. PubMed ID: 8595153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.
    von Deimling A; Louis DN; von Ammon K; Petersen I; Wiestler OD; Seizinger BR
    Cancer Res; 1992 Aug; 52(15):4277-9. PubMed ID: 1353411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer.
    Jarrard DF; Bova GS; Ewing CM; Pin SS; Nguyen SH; Baylin SB; Cairns P; Sidransky D; Herman JG; Isaacs WB
    Genes Chromosomes Cancer; 1997 Jun; 19(2):90-6. PubMed ID: 9171999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma.
    Ohta M; Berd D; Shimizu M; Nagai H; Cotticelli M-G ; Mastrangelo M; Shields JA; Shields CL; Croce CM; Huebner K
    Int J Cancer; 1996 Mar; 65(6):762-7. PubMed ID: 8631588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FISH analysis of translocations involving the short arm of chromosome 9 in lymphoid malignancies.
    Leblanc T; Derré J; Flexor M; Le Coniat M; Leroux D; Rimokh R; Larsen CJ; Berger R
    Genes Chromosomes Cancer; 1997 Aug; 19(4):273-7. PubMed ID: 9258663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma.
    Takita J; Hayashi Y; Kohno T; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
    Cancer Res; 1997 Mar; 57(5):907-12. PubMed ID: 9041193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
    Ono Y; Tamiya T; Ichikawa T; Kunishio K; Matsumoto K; Furuta T; Ohmoto T; Ueki K; Louis DN
    J Neuropathol Exp Neurol; 1996 Oct; 55(10):1026-31. PubMed ID: 8857999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cell cycle regulator potentially involved in genesis of many tumor types.
    Kamb A; Gruis NA; Weaver-Feldhaus J; Liu Q; Harshman K; Tavtigian SV; Stockert E; Day RS; Johnson BE; Skolnick MH
    Science; 1994 Apr; 264(5157):436-40. PubMed ID: 8153634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of p16/MTS1 gene mutations in human prostate cancer.
    Chen W; Weghorst CM; Sabourin CL; Wang Y; Wang D; Bostwick DG; Stoner GD
    Carcinogenesis; 1996 Dec; 17(12):2603-7. PubMed ID: 9006095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p16INK4 gene mutation and allelic loss of chromosome 9p21-22 in Taiwanese hepatocellular carcinoma.
    Chen TC; Hsieh LL; Kuo TT; Ng KF; Wu Chou YH; Jeng LB; Chen MF
    Anticancer Res; 2000; 20(3A):1621-6. PubMed ID: 10928081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds.
    Walker GJ; Hussussian CJ; Flores JF; Glendening JM; Haluska FG; Dracopoli NC; Hayward NK; Fountain JW
    Hum Mol Genet; 1995 Oct; 4(10):1845-52. PubMed ID: 8595405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.